Guyi Wang

1.1k total citations
32 papers, 732 citations indexed

About

Guyi Wang is a scholar working on Infectious Diseases, Neurology and Surgery. According to data from OpenAlex, Guyi Wang has authored 32 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Neurology and 6 papers in Surgery. Recurrent topics in Guyi Wang's work include COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (7 papers) and Asthma and respiratory diseases (4 papers). Guyi Wang is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), Long-Term Effects of COVID-19 (7 papers) and Asthma and respiratory diseases (4 papers). Guyi Wang collaborates with scholars based in China and United States. Guyi Wang's co-authors include Chenfang Wu, Guobao Wu, Yanjun Zhong, Bo Yu, Siye Zhang, Quan Zhang, Jianlei Lv, Fang Wu, Haiyun Dong and Shangjie Wu and has published in prestigious journals such as Scientific Reports, Life Sciences and Critical Care.

In The Last Decade

Guyi Wang

31 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guyi Wang China 15 399 167 152 119 89 32 732
Edison Jahaj Greece 17 338 0.8× 165 1.0× 157 1.0× 130 1.1× 103 1.2× 73 735
Bas C. T. van Bussel Netherlands 16 202 0.5× 125 0.7× 97 0.6× 55 0.5× 62 0.7× 73 850
Jianlei Cao China 13 345 0.9× 232 1.4× 116 0.8× 205 1.7× 34 0.4× 31 816
Mengda Xu China 8 643 1.6× 341 2.0× 174 1.1× 154 1.3× 22 0.2× 9 959
Shaghayegh Khanmohammadi Iran 12 239 0.6× 125 0.7× 185 1.2× 149 1.3× 93 1.0× 37 766
Zhaolong Cao China 5 517 1.3× 229 1.4× 66 0.4× 151 1.3× 32 0.4× 8 854
Tracey J. Wright United Kingdom 8 361 0.9× 116 0.7× 46 0.3× 147 1.2× 37 0.4× 9 764

Countries citing papers authored by Guyi Wang

Since Specialization
Citations

This map shows the geographic impact of Guyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guyi Wang more than expected).

Fields of papers citing papers by Guyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guyi Wang. The network helps show where Guyi Wang may publish in the future.

Co-authorship network of co-authors of Guyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guyi Wang. A scholar is included among the top collaborators of Guyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guyi Wang. Guyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yang, Guifang Yang, Jiqiang Liu, et al.. (2025). MBD2 promotes epithelial-to-mesenchymal transition (EMT) and ARDS-related pulmonary fibrosis by modulating FZD2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167798–167798. 2 indexed citations
2.
Liu, Xiaowei, et al.. (2025). Music intervention for neurodevelopment in the pediatric population: a systematic review and meta-analysis. Scientific Reports. 15(1). 10388–10388.
3.
Liu, Da, Lang Hu, Yina Wang, et al.. (2024). Saccharomyces boulardii alleviates allergic asthma by restoring gut microbiota and metabolic homeostasis via up-regulation of METTL3 in an m6A-dependent manner. Immunology Letters. 267. 106853–106853. 7 indexed citations
4.
Li, Fanglin, Guyi Wang, Min Xu, et al.. (2023). The differences in virus shedding time between the Delta variant and original SARS-CoV-2 infected patients. Frontiers in Public Health. 11. 1132643–1132643. 3 indexed citations
5.
Zhang, Dandan, et al.. (2023). Online-merge-offline (OMO)-based music therapy for asthmatic children during the COVID-19 pandemic in China. European Journal of Pediatrics. 183(3). 1277–1286. 3 indexed citations
6.
Yuan, Yu, Wentao Duan, Danhong Li, et al.. (2023). Inhibition of METTL3 alleviated LPS-induced alveolar epithelial cell apoptosis and acute lung injury via restoring neprilysin expression. Life Sciences. 333. 122148–122148. 21 indexed citations
7.
He, Wenfang, Chenfang Wu, Yanjun Zhong, et al.. (2022). Case Report: Therapeutic Strategy With Delayed Debridement for Culture-Negative Invasive Group A Streptococcal Infections Diagnosed by Metagenomic Next-Generation Sequencing. Frontiers in Public Health. 10. 899077–899077. 3 indexed citations
8.
Wang, Guyi, et al.. (2022). The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy. Frontiers in Pharmacology. 13. 791922–791922. 31 indexed citations
9.
Li, Fanglin, Chenfang Wu, Bo Yu, et al.. (2022). Pulmonary fibrosis in patients with COVID-19: A retrospective study. Frontiers in Cellular and Infection Microbiology. 12. 1013526–1013526. 8 indexed citations
10.
Wu, Chenfang, Guyi Wang, Bo Yu, et al.. (2021). Association Between Respiratory Alkalosis and the Prognosis of COVID-19 Patients. Frontiers in Medicine. 8. 564635–564635. 16 indexed citations
11.
Gong, Subo, Xiaoying Ji, Jing Su, et al.. (2021). Yeast Fermentate Prebiotic Ameliorates Allergic Asthma, Associating with Inhibiting Inflammation and Reducing Oxidative Stress Level through Suppressing Autophagy. Mediators of Inflammation. 2021(1). 4080935–4080935. 18 indexed citations
12.
Zhong, Yanjun, Lishu Zhao, Guobao Wu, et al.. (2020). Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study. Journal of International Medical Research. 48(12). 1220778703–1220778703. 15 indexed citations
13.
Wang, Guyi, Quan Zhang, Haiyun Dong, et al.. (2020). Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids in Health and Disease. 19(1). 204–204. 113 indexed citations
14.
Wang, Guyi, Chenfang Wu, Quan Zhang, et al.. (2020). Clinical characteristics and the risk factors for severe events of elderly coronavirus disease 2019 patients.. PubMed. 45(5). 542–548. 6 indexed citations
15.
Wang, Guyi, Quan Zhang, Chenfang Wu, et al.. (2020). Clinical Characteristics of Adult Fevered COVID-19 Patients and Predictors for Developing Severe Events. Frontiers in Medicine. 7. 324–324. 9 indexed citations
16.
Zou, Gen, et al.. (2017). Danger of injudicious use of tui-na therapy in ankylosing spondylitis. European Spine Journal. 26(S1). 178–180. 7 indexed citations
17.
Wang, Guyi, et al.. (2016). Lung ultrasound: a promising tool to monitor ventilator-associated pneumonia in critically ill patients. Critical Care. 20(1). 320–320. 41 indexed citations
18.
Dong, Haiyun, Jinxiu Li, Yanyan Zhou, et al.. (2013). Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase. BMC Immunology. 14(1). 25–25. 30 indexed citations
20.
Liu, Yi, Guyi Wang, Shaokun Liu, et al.. (2011). β-arrestin2 stimulates interleukin-17 production and expression of CD4+ T lymphocytes in a murine asthma model.. PubMed. 10(3). 171–82. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026